CURE’s rare cancers page is a go-to resource for oncology news and updates in the world of rare cancers Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in rare cancers.
Patients with neuroendocrine tumors have more treatment options than ever before.
March 20th 2024, 5:00pm
The waiting in between scans heightens my scanxiety, even though I've had no evidence of disease for 2 1/2 years.
March 14th 2024, 9:00pm
Of all the bad whatifs about cancer that creep into my ear, what if I turned them into positive whatifs?
March 6th 2024, 4:00pm
In some patients with rare cancers, certain strains of gut bacteria could boost responses to immunotherapy combinations, researchers established.
March 5th 2024, 10:00pm
Lutathera plus Sandostatin improved progression-free survival in patients with advanced gastric neuroendocrine tumors, research showed.
March 3rd 2024, 6:00pm
After reading about breast cancer and aromatase inhibitors, a light went on for me about my leiomyosarcoma diagnosis.
February 27th 2024, 2:00pm
Patients with locally advanced penile squamous cell carcinoma who responded to neoadjuvant chemotherapy followed by consolidative lymphadenectomy experienced improved long-term survival outcomes.
January 5th 2024, 4:00pm
From Shannen Doherty discussing in-vitro fertilization before breast cancer to "Chickadee" Cardwell's cancer experience to be featured on an upcoming TV series, here's what's happening in the oncology space this week.
December 18th 2023, 10:00pm
After being diagnosed with stage 3 liposarcoma, my life’s choices came sharply into focus.
November 3rd 2023, 9:00pm
When I was diagnosed with a rare cancer at the “stump” of my appendix, I was surprised, considering I had my appendix removed more than a decade ago.
November 2nd 2023, 1:00pm
I was diagnosed with a rare cancer in 2007, and it shaped who I am today.
Radiotherapy and EGFR-TKIs May Improve Treatment Outcomes in Lung Cancer
FDA Approves Ziihera for Some With Biliary Tract Cancer
PD-L1, KIM-1 Levels May Predict Kidney Cancer Response to Opdivo, Yervoy
Donor Lymphocyte Infusion May Improve Survival in R/R MDS